PFM Health Sciences’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
DGM
PFM Health Sciences's GMAB Position: Q3 2026 in Review
PFM Health Sciences opened a new position in Genmab (GMAB) in Q3 2026: 313,679 shares worth $11.2M. The stake represents 1.12% of the portfolio and ranks #32 among its holdings.
333 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- PFM Health Sciences held 313,679 shares of Genmab worth $11.2M as of Q3 2026.
- Genmab was a new PFM Health Sciences position in Q3 2026.
- Genmab made up 1.12% of PFM Health Sciences's portfolio in Q3 2026, its #32 holding.
- 333 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on PFM Health Sciences's 13F filing for Q3 2026, filed 16 Nov 2026.